List view / Grid view
4 June 2015 | By Victoria White
UK patients with rheumatoid arthritis now have more choice for managing their condition with the launch of the ClickJect Pre-Filled pen...
4 June 2015 | By Victoria White
Catabasis has announced preliminary Phase 1 clinical trial data for CAT-2054 - its candidate for the potential treatment of hypercholesterolaemia...
4 June 2015 | By Victoria White
Blaze Bioscience has announced open enrollment for the first clinical study of Tumour Paint BLZ-100 in children with brain cancer...
4 June 2015 | By Victoria White
Exalenz Bioscience has initiated a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer...
4 June 2015 | By Victoria White
Results from a Phase 2a clinical trial of emixustat in geographic atrophy associated with dry age-related macular degeneration have been published...
4 June 2015 | By Victoria White
AVEO has received confirmation of support from two CHMP members following pre-submission meetings to discuss the potential submission of a MAA for tivozanib...
4 June 2015 | By Victoria White
The FDA has granted Breakthrough Therapy designation to Genzyme’s olipudase alfa for the treatment of Niemann-Pick disease type B...
3 June 2015 | By Victoria White
Amicus Therapeutics has submitted a MAA to request full approval in the EU of Galafold for Fabry patients who have amenable genetic mutations...
3 June 2015 | By Victoria White
The EC has approved Akynzeo for use in the European Union for the prevention of acute and delayed chemotherapy-induced nausea and vomiting...
3 June 2015 | By
The EMA has approved Resolor for use in adults for the symptomatic treatment of chronic constipation in whom laxatives fail to provide adequate relief...
3 June 2015 | By Victoria White
Dezima Pharma has announced the publication of the phase 2b TULIP study results with its CETP inhibitor, TA-8995, in patients with mild dyslipidaemia...
3 June 2015 | By Victoria White
The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in the Republic of Korea continues to evolve, says WHO...
3 June 2015 | By Victoria White
Boehringer Ingelheim’s VARGATEF in combination with docetaxel has been recommended for use within the National Health Service (NHS) in England and Wales...
3 June 2015 | By Victoria White
Janssen Research & Development has announced data from a Phase 3 study of trabectedin (YONDELIS) in patients with two common types of soft tissue sarcoma...
3 June 2015 | By Victoria White
AbbVie has announced findings from a Phase 2 study of a veliparib regimen in patients with non-small cell lung cancer (NSCLC) who are current smokers...
